Krsnaa Diagnostics Reports Robust Q2 FY27 Topline Growth of 32% YoY
Krsnaa Diagnostics Ltd 路 Investor Presentation 路 03 Nov 2026, 12:16 am
Krsnaa Diagnostics Reports Robust Q2 FY27 Topline Growth of 32% YoY Krsnaa Diagnostics delivered strong performance for Q2 FY27, with revenue growing 32% YoY to INR 2,710 mn, driven by an 85% YoY surge in tests performed (30.3 mn) and a 35% YoY increase in patients served (7.3 mn). Retail revenue rose 35% YoY to INR 235 mn. EBITDA (pre-CSR/ESOP) increased 20% YoY to INR 719 mn, while margins contracted 200 bps to 27% due to upfront fixed costs for Rajasthan labs. PAT rose 3% YoY to INR 246 mn. For H1 FY27, revenue reached INR 5,065 mn.
Original exchange filing (PDF)
More announcements from Krsnaa Diagnostics Ltd
- Earnings Call Transcript for quarter and half year ended September 30, 2026 路 08 Nov 2026
- Intimation of Change in Corporate office of Registrar and Sahre Trasnfer Agent of the Company w.e.f. 1st December 2026. 路 04 Nov 2026
- Audio recording of conference call for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Submission of Certificate obtained from Statutory Auditors in terms of Regulation 169(5) of the SEBI ICDR Regulations, 2018 路 03 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Krsnaa Diagnostics secures 15 year Cash based PPP project from Municipal corporation of Delhi for Advanced CT Scan and .... 路 03 Nov 2026
- Press Release - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 路 03 Nov 2026
- Financial Results for Quarter and Half Year ended September 30, 2026 路 02 Nov 2026
- Krsnaa Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
